- CMC Biologics today announced the execution of an ...
- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...
- - Findings from Two-Year Pivotal Phase III TEMSO Trial ...
- March 2011 Data Confirm Strong Treatment Effect of ...
- - elure Advanced Skin Lightening Products captures the ...
- - Polyplus-transfection celebrates 10 years of commercial growth and research and ...
- Call for Nations to ...
- - Positive Correlation Established Between Valdoxan's Efficacy and Disease ...
- - This release is not intended for US and Canadian media ...
-Initial Results are Encouraging, Spurring Hope for a Treatment Option with a Lower Rate of ...
The first ASEAN Dengue Day was observed on June 15 at Jakarta`s National Museum on June 15, where a call was made to ...
-FDA allows use of investigational new drug for life-threatening indications Edison ...
Gadjah Mada University (UGM) will hold a national seminar on the benefits, safety and development prospects of ...
- Polyplus-transfection SA, a privately-held company developing innovative ...
- Cytotech Labs, a Boston based pharmaceutical company and member of the Berg ...